EC Number   |
Application |
Reference |
|---|
   4.1.1.2 | agriculture |
control of fungal plant pathogen |
-, 713879 |
| 4.1.1.2 | agriculture |
development of transgenic plants resistant to fungal infection, transgenic tobacco and tomato plants expressing oxalate decarboxylase show remarkable resistance to phytopathogenic fungus Sclerotinia sclerotiorum that utilizes oxalic acid during infestation |
652089 |
| 4.1.1.2 | agriculture |
the enzyme represents a potentially source of resistance against oxalate- and Nep1-like protein-producing pathogens such as Moniliophthora perniciosa, the causal agent of witches' broom disease of cacao, Theobroma cacao |
728346 |
| 4.1.1.2 | biotechnology |
determination of oxalic acid in food and biological samples like urine, plasma, serum, wort and beer |
-, 713879 |
| 4.1.1.2 | degradation |
oxalic acid removal in industrial bleaching plant filtrates containing oxalic acid |
695712 |
| 4.1.1.2 | industry |
prevention of scaling in pulp and paper industry, depletion of oxalate from beverage |
713879 |
| 4.1.1.2 | medicine |
HEK-293 cells expressing the enzyme capable of degrading oxalate protect cells from oxidative damage and thus serve as a therapeutic option for prevention of calcium oxalate stone disease |
748313 |
| 4.1.1.2 | medicine |
OxDc-CLEC reduces hyperoxaluria and ameliorates nephrocalcinosis and urolithiasis |
690331 |
| 4.1.1.2 | medicine |
the transgenic Lactobacillus plantarum strain WCFS1 expressing the enzyme from Bacillus subtilis may provide possible therapeutic approach by degrading intestinal oxalate in the human host of Lactobacillus plantarum |
727124 |
| 4.1.1.2 | medicine |
treatment of hyperoxaluria, urolithiasis, nephrocalcinosis, and depletion of dietary oxalate with enzyme formulation |
713879 |
